Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Takayasu's arteritis and atherosclerosis].

A Hatri1, R Guermaz2, J-P Laroche3

  • 1Unité de médecine vasculaire, clinique d'Elbiar, Alger, Algérie.

Journal De Medecine Vasculaire
|September 3, 2019
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Isolated distal deep vein thrombosis: What have we learnt from the OPTIMEV study?

Journal de medecine vasculaire·2023
Same author

Milk production and efficiency of utilization of nitrogen, metabolizable protein, and amino acids are affected by protein and energy supplies in dairy cows fed alfalfa-based diets.

Journal of dairy science·2021
Same author

Subclinical atherosclerosis and arterial stiffness in nonalcoholic fatty liver disease: A case-control study in Algerian population.

Journal de medecine vasculaire·2021
Same author

[Prevalence and risk factors of sub-renal abdominal aortic aneurysm in an Algerian population aged over 60].

Journal de medecine vasculaire·2018
Same author

[Cardiovascular risk factors in Algeria. Analysis of the subgroup from the "Africa/Middle East Cardiovascular Epidemiological" Study].

Annales de cardiologie et d'angeiologie·2018
Same author

[Hypertension during Takayasu's disease: An Algerian single center experience of 279 patients].

Annales de cardiologie et d'angeiologie·2017

Takayasu's arteritis and rheumatoid arthritis patients exhibit accelerated atherosclerosis, even with low cardiovascular risk. Inflammation plays a key role, necessitating proactive cardiovascular prevention strategies for Takayasu's disease.

Area of Science:

  • Cardiovascular Medicine
  • Rheumatology
  • Vascular Biology

Background:

  • Chronic inflammatory diseases like SLE and RA increase cardiovascular morbidity and mortality due to premature atherosclerosis.
  • Atherosclerosis is linked to chronic systemic inflammation, independent of traditional cardiovascular risk factors.
  • Large artery vasculitis, such as Takayasu's disease, involves both systemic and local vascular inflammation.

Purpose of the Study:

  • To investigate the prevalence and characteristics of atherosclerosis in patients with Takayasu's arteritis compared to rheumatoid arthritis and controls.
  • To assess the role of inflammation in the development of premature atherosclerosis in these patient groups.

Main Methods:

  • A prospective case-control study involving 64 Takayasu's arteritis patients, 50 RA patients, and a control group.
Keywords:
AthéroscléroseMaladie de TakayasuTakayasu's diseaseatherosclerosis

Related Experiment Videos

  • Assessment of classic cardiovascular risk factors and calculation of risk using the Framingham equation.
  • Measurement of carotid intima-media thickness (IMT) and evaluation for carotid, aortic, and femoral atheroma.
  • Main Results:

    • No significant difference in calculated cardiovascular risk was observed between Takayasu's, RA, and control groups.
    • Subclinical atherosclerosis (IMT > 0.70mm and/or atheroma plaque) was significantly higher in Takayasu's patients (87%) and RA patients (76%) compared to controls (48%).
    • Carotid IMT was significantly higher in Takayasu's patients (0.91mm) compared to RA patients (0.76mm) and controls (0.71mm).

    Conclusions:

    • Atherosclerosis in Takayasu's disease is accelerated and premature, occurring in younger individuals with low cardiovascular risk.
    • Systemic and local inflammation in Takayasu's arteritis likely drives accelerated atherosclerosis.
    • An active cardiovascular prevention strategy is recommended for patients with Takayasu's disease.